Bad Brakes Send Scientist to Biotechnology

Judith Britz decided to leave academic science for industry during her morning commute one day in 1986. She had exited Interstate 95 on the way to work as a postdoctorate fellow at the Johns Hopkins School of Medicine. But when she pulled onto the off ramp and hit the brakes, she didn't slow down. "The brakes failed and scared the hell out of me," says Britz. "I was able to stop the car with my hand brake. I was so frightened and at the same time angry because we had replaced the brakes before a

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

It was $200 the Britz family didn't have. She and her husband, a plant physiologist with the US Department of Agriculture, were rearing three children, and Judy earned only $18,000 a year. "I thought, this is too much," recalls Britz, whose credentials include a graduate degree from the Massachusetts Institute of Technology, a doctorate from the Stanford University School of Medicine, and a postdoctorate fellowship from Yale University. "Love is a great motivator of work, but sometimes it's not enough. I thought it was no longer fair and I deserved more compensation for that education."

So that morning, still shaking inside her brakeless, 8-year-old car, Britz made a "practical decision." She would cash in her dream of becoming a university research scientist and take a job in industry. Fifteen years later, the 51-year-old Britz is president and CEO of Cylex Inc., a Maryland biotechnology company. But perhaps more important, she ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Calandra

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo